APGE
Price
$55.21
Change
+$2.84 (+5.42%)
Updated
Oct 15, 12:59 PM (EDT)
Capitalization
3.65B
34 days until earnings call
Intraday Buy/Sell Signals
RCUS
Price
$15.61
Change
-$0.01 (-0.06%)
Updated
Oct 15, 12:15 PM (EDT)
Capitalization
1.66B
27 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APGE vs RCUS

Header iconAPGE vs RCUS Comparison
Open Charts APGE vs RCUSBanner chart's image
Apogee Therapeutics
Price$55.21
Change+$2.84 (+5.42%)
Volume$3.18K
Capitalization3.65B
Arcus Biosciences
Price$15.61
Change-$0.01 (-0.06%)
Volume$100
Capitalization1.66B
APGE vs RCUS Comparison Chart in %
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. RCUS commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (APGE: $52.37 vs. RCUS: $15.62)
Brand notoriety: APGE and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 131% vs. RCUS: 144%
Market capitalization -- APGE: $3.65B vs. RCUS: $1.66B
APGE [@Biotechnology] is valued at $3.65B. RCUS’s [@Biotechnology] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 4 bearish.
  • RCUS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than RCUS.

Price Growth

APGE (@Biotechnology) experienced а +31.81% price change this week, while RCUS (@Biotechnology) price change was +11.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.66%. For the same industry, the average monthly price growth was +17.73%, and the average quarterly price growth was +82.74%.

Reported Earning Dates

APGE is expected to report earnings on Nov 18, 2025.

RCUS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($3.65B) has a higher market cap than RCUS($1.66B). APGE YTD gains are higher at: 15.607 vs. RCUS (4.903). APGE (-270.1M) and RCUS (-282M) have comparable annual earnings (EBITDA) . RCUS has more cash in the bank: 911M vs. APGE (505M). APGE has less debt than RCUS: APGE (10.8M) vs RCUS (109M). RCUS has higher revenues than APGE: RCUS (262M) vs APGE (0).
APGERCUSAPGE / RCUS
Capitalization3.65B1.66B220%
EBITDA-270.1M-282M96%
Gain YTD15.6074.903318%
P/E RatioN/AN/A-
Revenue0262M-
Total Cash505M911M55%
Total Debt10.8M109M10%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
72%
Bearish Trend 13 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGOAX20.96N/A
N/A
PGIM Jennison Small Company A
RGBEX41.11N/A
N/A
American Funds Global Balanced R4
VPRDX11.21N/A
N/A
VY® Morgan Stanley Global Franchise R6
MLNSX27.64N/A
N/A
Morgan Stanley Instl Glbl Concntr R6
SPMHX8.19N/A
N/A
Invesco SteelPath MLP Alpha R5

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-6.13%
XNCR - RCUS
52%
Loosely correlated
-11.03%
IDYA - RCUS
48%
Loosely correlated
+1.12%
APGE - RCUS
48%
Loosely correlated
-2.96%
TRDA - RCUS
48%
Loosely correlated
+4.48%
IMNM - RCUS
47%
Loosely correlated
-1.26%
More